公开(公告)号：US5916889A

公开(公告)日：1999-06-29

申请号：US943726

申请日：1997-10-03

申请人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

发明人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

IPC分类号： C07D295/06 ,  A61K31/4427 ,  A61K31/4436 ,  A61K31/444 ,  A61K31/495 ,  A61K31/496 ,  A61K31/55 ,  A61P3/08 ,  A61P17/04 ,  A61P25/06 ,  A61P29/00 ,  C07D213/74 ,  C07D213/79 ,  C07D213/80 ,  C07D295/073 ,  C07D295/12 ,  C07D295/14 ,  C07D295/155 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/06 ,  C07D413/12 ,  C07D413/14 ,  C07D405/06

CPC分类号： C07D213/74 ,  C07D213/79 ,  C07D295/073 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07C2103/78

摘要： The present invention relates to 1,4-disubstituted piperazines of the general formula ##STR1## wherein X, Y, Z, R.sup.1, R.sup.2 and r are as defined in the detailed part of the present description or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for the treatment of indications caused by or related to the secretion and circulation of insulin antagonizing peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.

摘要翻译： 本发明涉及以下通式的1,4-二取代哌嗪其中X，Y，Z，R 1，R 2和r如在本说明书的详细部分或其盐中所定义，其制备方法，组合物 并且用于临床治疗疼痛，痛觉过敏和/或炎性疾病，其中C纤维通过引发神经源性疼痛或炎症而发挥病理生理学作用，以及它们用于治疗由...引起的或与之相关的适应症 胰岛素拮抗肽的分泌和循环，例如 非胰岛素依赖性糖尿病（NIDDM）和衰老相关性肥胖。

公开(公告)号：US6133268A

公开(公告)日：2000-10-17

申请号：US271564

申请日：1999-03-18

申请人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

发明人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

IPC分类号： C07D295/06 ,  A61K31/4427 ,  A61K31/4436 ,  A61K31/444 ,  A61K31/495 ,  A61K31/496 ,  A61K31/55 ,  A61P3/08 ,  A61P17/04 ,  A61P25/06 ,  A61P29/00 ,  C07D213/74 ,  C07D213/79 ,  C07D213/80 ,  C07D295/073 ,  C07D295/12 ,  C07D295/14 ,  C07D295/155 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/06 ,  C07D413/12 ,  C07D413/14

CPC分类号： C07D213/74 ,  C07D213/79 ,  C07D295/073 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07C2103/78

摘要： The present invention relates to 1,4-disubstituted piperazines of the general formula ##STR1## wherein X, Y, Z, R.sup.1, R.sup.2 and r are as defined in the detailed part of the present description or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for the treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.

摘要翻译： 本发明涉及以下通式的1,4-二取代哌嗪其中X，Y，Z，R 1，R 2和r如在本说明书的详细部分或其盐中所定义，其制备方法，组合物 并且用于临床治疗疼痛，痛觉过敏和/或炎性疾病，其中C纤维通过引发神经源性疼痛或炎症而发挥病理生理学作用，以及它们用于治疗由...引起的或与之相关的适应症 胰岛素拮抗肽的分泌和循环，例如 非胰岛素依赖性糖尿病（NIDDM）和衰老相关性肥胖。

公开(公告)号：US6040302A

公开(公告)日：2000-03-21

申请号：US271565

申请日：1999-03-18

申请人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

发明人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

IPC分类号： C07D295/06 ,  A61K31/4427 ,  A61K31/4436 ,  A61K31/444 ,  A61K31/495 ,  A61K31/496 ,  A61K31/55 ,  A61P3/08 ,  A61P17/04 ,  A61P25/06 ,  A61P29/00 ,  C07D213/74 ,  C07D213/79 ,  C07D213/80 ,  C07D295/073 ,  C07D295/12 ,  C07D295/14 ,  C07D295/155 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/06 ,  C07D413/12 ,  C07D413/14

CPC分类号： C07D213/74 ,  C07D213/79 ,  C07D295/073 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07C2103/78

摘要： The present invention relates to 1,4-disubstituted piperazines of the general formula ##STR1## wherein X, Y, Z, R.sup.1, R.sup.2 and r are as defined in the detailed part of the present description or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for the treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.

公开(公告)号：US6004961A

公开(公告)日：1999-12-21

申请号：US271785

申请日：1999-03-18

申请人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

发明人： Rolf Hohlweg ,  Peter Madsen ,  Tine Krogh J.o slashed.rgensen ,  Knud Erik Andersen ,  Brett Watson ,  Zdenek Polivka ,  Otylie Konigova ,  Martina Kovandova ,  Alexandra Silhankova ,  Vladimir Valenta

IPC分类号： C07D295/06 ,  A61K31/4427 ,  A61K31/4436 ,  A61K31/444 ,  A61K31/495 ,  A61K31/496 ,  A61K31/55 ,  A61P3/08 ,  A61P17/04 ,  A61P25/06 ,  A61P29/00 ,  C07D213/74 ,  C07D213/79 ,  C07D213/80 ,  C07D295/073 ,  C07D295/12 ,  C07D295/14 ,  C07D295/155 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/06 ,  C07D413/12 ,  C07D413/14

CPC分类号： C07D213/74 ,  C07D213/79 ,  C07D295/073 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07C2103/78

摘要： The present invention relates to 1,4-disubstituted piperazines of the general formula ##STR1## wherein X, Y, Z, R.sup.1, R.sup.2 and r are as defined in the detailed part of the present description or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for the treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.

公开(公告)号：US06277991B1

公开(公告)日：2001-08-21

申请号：US09311469

申请日：1999-05-13

申请人： Rolf Hohlweg ,  Brett Watson ,  Christain Thomsen

发明人： Rolf Hohlweg ,  Brett Watson ,  Christain Thomsen

IPC分类号： A61K3805

CPC分类号： C07D471/10 ,  A61K9/2054

摘要： The present invention relates to the use of small organic compounds acting as opioid receptor ligands for the treatment of vasomotor disturbances. In particular the present invention relates to the use of triaza-spiro compounds of formula wherein R1, R2, R3, R4, R5, z and n are defined in the specification, for the treatment of migraine, non-insulin dependent diabetes mellitus (type II diabetes), sepsis, inflammation, incontinence and/or vasomotor disturbances, in particular the peripheral vasomotor effects known as hot flushes or hot flashes.

摘要翻译： 本发明涉及作为阿片受体配体的小有机化合物用于治疗血管运动障碍的用途。 特别地，本发明涉及在本说明书中定义的用于治疗偏头痛，非胰岛素依赖型糖尿病（II型糖尿病）的方案 ），败血症，炎症，失禁和/或血管舒缩障碍，特别是被称为热潮红或热潮红的周围血管运动作用。

公开(公告)号：US20130200045A1

公开(公告)日：2013-08-08

申请号：US13808642

申请日：2011-06-29

申请人： Brett Watson

发明人： Brett Watson

IPC分类号： H01H9/00 ,  H01H9/30

CPC分类号： H01H9/0066 ,  H01H9/30 ,  H01H33/24 ,  H01H33/64 ,  H01H33/662 ,  H01H33/6661 ,  H01H2033/66284

摘要： An electrical isolator includes a body defining an aperture therethrough, a first electrical contact disposed at a first end of the aperture, a second electrical contact movably disposed at a second end of the aperture, the second contact configured to be operatively movable through the aperture to electrically connect to, or disconnect from, the first contact and at least two concave electrical field control screens fixed to the body at respective ends of, and about, the aperture such that the screens lie transverse to the aperture and an open-end of each concave screen is directed towards the other.

摘要翻译： 电隔离器包括限定穿过其中的孔的主体，设置在孔的第一端处的第一电触点，可移动地设置在孔的第二端处的第二电触点，被配置为可操作地移动穿过孔的第二触点 电连接到第一接触件或与其断开连接，以及至少两个凹入的电场控制屏蔽件，其在孔的相应端部处固定到主体，并且在孔的相应端部附近，使得屏幕横向于孔径并且每个开口端 凹形屏幕指向另一个。

公开(公告)号：US6127391A

公开(公告)日：2000-10-03

申请号：US218686

申请日：1998-12-21

申请人： Thomas Kruse Hansen ,  Bernd Peschke ,  Jesper Lau ,  Behrend Friedrich Lundt ,  Michael Ankersen ,  Brett Watson ,  Kjeld Madsen

发明人： Thomas Kruse Hansen ,  Bernd Peschke ,  Jesper Lau ,  Behrend Friedrich Lundt ,  Michael Ankersen ,  Brett Watson ,  Kjeld Madsen

IPC分类号： C07D333/20 ,  A61K31/00 ,  A61K31/17 ,  A61K31/18 ,  A61K31/216 ,  A61K31/27 ,  A61K31/38 ,  A61K31/381 ,  A61K31/41 ,  A61K31/4245 ,  A61K31/454 ,  A61K38/00 ,  A61K38/07 ,  A61K38/08 ,  A61P3/00 ,  A61P5/00 ,  A61P5/06 ,  A61P5/10 ,  A61P15/00 ,  A61P15/14 ,  A61P19/00 ,  B41J19/20 ,  C07C237/00 ,  C07C237/22 ,  C07C311/05 ,  C07C335/14 ,  C07D213/12 ,  C07D227/00 ,  C07D271/06 ,  C07D333/00 ,  C07D333/24 ,  C07D333/60 ,  C07D409/00 ,  C07D413/12 ,  C07K5/03 ,  C07K5/06 ,  C07K5/065 ,  C07K5/078 ,  C07K5/10 ,  C07K7/02 ,  C07K14/60 ,  A61K31/4439 ,  C07D401/12

CPC分类号： C07D271/06 ,  B41J19/205 ,  C07C237/22 ,  C07D333/24 ,  C07D413/12 ,  C07K5/0606 ,  C07K5/06078 ,  C07K5/06139 ,  C07K5/06191 ,  A61K38/00

摘要： Compounds of peptide mimetic nature having the general formula I ##STR1## wherein a and b are independently 1 or 2, R.sup.1 and R.sup.2 are independently H or C.sub.1-6 alkyl, G and J are independently, inter alia, aromats, and D and E are independently several different groups are growth hormone secretagogous with improved bioavailability.

摘要翻译： 具有通式I的肽模拟性质的化合物，其中a和b独立地为1或2，R 1和R 2独立地为H或C 1-6烷基，G和J独立地为芳族，D和E独立地为数个不同的 组是具有改善的生物利用度的促分泌素。

公开(公告)号：US10091885B2

公开(公告)日：2018-10-02

申请号：US15320880

申请日：2015-07-13

申请人： David Russell Murray ,  Brett Watson

发明人： David Russell Murray ,  Brett Watson

IPC分类号： H02M3/335 ,  H05K1/18 ,  H02M7/00 ,  H05K1/02 ,  H02M7/06

摘要： An electrical power conversion system for converting a high voltage from a HV electrical power supply to a low voltage is disclosed. In an embodiment, the electrical power conversion system includes at least one power converter and at least one RC network including a plurality of resistive components and a plurality of capacitive components electrically connected in series. In an embodiment, the at least one RC network is in series connection with the at least one power converter and the at least one RC network and at least one power converter are arranged to be connected across a line potential of the HV electrical power supply.

公开(公告)号：US5977178A

公开(公告)日：1999-11-02

申请号：US769020

申请日：1996-12-18

申请人： Thomas Kruse Hansen ,  Bernd Peschke ,  Jesper Lau ,  Behrend Friedrich Lundt ,  Michael Ankersen ,  Brett Watson ,  Kjeld Madsen

发明人： Thomas Kruse Hansen ,  Bernd Peschke ,  Jesper Lau ,  Behrend Friedrich Lundt ,  Michael Ankersen ,  Brett Watson ,  Kjeld Madsen

IPC分类号： C07D333/20 ,  A61K31/00 ,  A61K31/17 ,  A61K31/18 ,  A61K31/216 ,  A61K31/27 ,  A61K31/38 ,  A61K31/381 ,  A61K31/41 ,  A61K31/4245 ,  A61K31/454 ,  A61K38/00 ,  A61K38/07 ,  A61K38/08 ,  A61P3/00 ,  A61P5/00 ,  A61P5/06 ,  A61P5/10 ,  A61P15/00 ,  A61P15/14 ,  A61P19/00 ,  B41J19/20 ,  C07C237/00 ,  C07C237/22 ,  C07C311/05 ,  C07C335/14 ,  C07D213/12 ,  C07D227/00 ,  C07D271/06 ,  C07D333/00 ,  C07D333/24 ,  C07D333/60 ,  C07D409/00 ,  C07D413/12 ,  C07K5/03 ,  C07K5/06 ,  C07K5/065 ,  C07K5/078 ,  C07K5/10 ,  C07K7/02 ,  C07K14/60 ,  A61K31/16 ,  C07C233/01

CPC分类号： C07D271/06 ,  B41J19/205 ,  C07C237/22 ,  C07D333/24 ,  C07D413/12 ,  C07K5/0606 ,  C07K5/06078 ,  C07K5/06139 ,  C07K5/06191 ,  A61K38/00

摘要： Compounds of peptide mimetic nature having the general formula I ##STR1## wherein a and b are independently 1 or 2, R.sup.1 and R.sup.2 are independently H or C.sub.1-6 alkyl, G and J are independently, inter alia, aromats, and D and E are independently several different groups are growth hormone secretagogous with improved bioavailability.

公开(公告)号：US20110148253A1

公开(公告)日：2011-06-23

申请号：US12644958

申请日：2009-12-22

申请人： James Robert Friend ,  Leslie Yu-Ming Yeo ,  Brett Watson

发明人： James Robert Friend ,  Leslie Yu-Ming Yeo ,  Brett Watson

IPC分类号： H02N2/04

CPC分类号： H02N2/103 ,  H02N2/003 ,  H02N2/0045 ,  H02N2/108

摘要： A piezoelectric actuator including a piezoelectric element and an elongate transducer mounted on the piezoelectric element. The transducer is formed from an elongate cylindrical member, and at least one helical slot is provided around the outer surface of the cylindrical member to enable coupling of resonance modes of the transducer when actuated by the piezoelectric element.

摘要翻译： 一种压电致动器，包括压电元件和安装在压电元件上的细长换能器。 换能器由细长的圆柱形构件形成，并且在圆柱形构件的外表面周围设置至少一个螺旋槽，以在由压电元件致动时能够耦合换能器的谐振模式。